You just read:

ViiV Healthcare Announces Superior Efficacy of Dolutegravir Versus Lopinavir/Ritonavir in Second-line HIV Treatment in Resource-limited Settings

News provided by

ViiV Healthcare

Jul 25, 2017, 09:03 ET